PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHeart arrest
MeSH D006323 - heart arrest
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006331:Heart diseases
0 Companies
0 Drugs
Success rate
D006323: 
Heart arrest
D016757:Sudden death cardiac
0 Companies
0 Drugs
Success rate
D058687:Out-of-hospital cardiac arrest
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaEpinephrine Epinephrine  2018-08-16   
MylanAtropine, Diphenoxylate Diphenoxylate Atropine  1982-01-01   
Atropine, EDROPHONIUM Enlon  1991-11-06   
Epinephrine Epi 2025-09-11 1987-12-22   
Armstrong PharmaceuticalsEpinephrine Epinephrine  1984-05-23   
Epinephrine Primatene Mist 2026-01-26 2018-11-07   
AbbVieAtropine Atropine  1987-01-30   
Atropine, Meperidine Atropine Demerol  1982-11-26   
AstraZenecaPrilocaine, Epinephrine Citanest  1982-01-01   
Epinephrine, Etidocaine Duranest  1982-01-01   
Lidocaine, Epinephrine Xylocaine W/ Epinephrine  1982-01-01   
WyethEpinephrine Bronitin Mist  1982-01-01   
Atropine, Meperidine Meperidine Atropine  1982-01-01   
Sterling WinthropEpinephrine Bronkaid Mist  1982-01-01   
3MEpinephrine Medihaler-epi  1982-01-01   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
70%
14/20
Phase 2
63%
15/24
Phase 3
18%
6/33
Approved: 3Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
AstraZeneca
1
2
3
4
5
6
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use